Viral Testing Core
病毒检测核心
基本信息
- 批准号:10548595
- 负责人:
- 金额:$ 3.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAIDS vaccine developmentAcquired Immunodeficiency SyndromeAffectAlgorithmsAnimal ModelAnimalsAntibodiesAntibody titer measurementAntiviral TherapyBiological AssayBreedingCOVID-19 pandemicCOVID-19 testingCaliforniaCaribbean regionChagas DiseaseConsensusDataDecision MakingDevelopmentEnsureEquipmentEventExposure toGoalsGrantHIVHealthHerpesvirus 1HumanHuman ResourcesImmune responseImmunizationImmunization ProgramsImmunoassayImmunologyInfectionInvestigationLaboratoriesMacacaMacaca mulattaMaintenanceMeaslesMeasles virusMethodsMonitorMonkeysMucous MembraneOregonParasitesPathogen detectionPatientsPest ControlPrevalencePrimatesPrincipal InvestigatorProceduresReagentRecombinantsRecommendationReliability of ResultsResearchResearch PersonnelResearch SupportReverse Transcriptase Polymerase Chain ReactionRhesusRiskSARS-CoV-2 antibodySIVSamplingSerologySerology testSerumSimian RetrovirusesSystemTechniquesTestingTimeTrypanosoma cruziU-Series Cooperative AgreementsUnited States National Institutes of HealthViralViral PathogenesisVirusWashingtonanimal careantibody detectioneffectiveness evaluationefficacy evaluationgerm free conditionimprovedinstrumentinterestmemberpathogenprogramsscreeningsimian human immunodeficiency virusviral RNAworking group
项目摘要
Abstract – Core B: Viral Testing Core
The Viral Testing Core is a critical component for the maintenance of a Specific Pathogen Free (SPF) Indian
rhesus macaque (Ind RM) (Macaca mulatta) breeding colony. Rhesus macaques infected with the Simian
Immunodeficiency Virus (SIV) are the preferred animal model for AIDS studies and are used to examine many
aspects of viral pathogenesis, AIDS vaccine development, and exploratory new systemic and mucosal antiviral
therapies, including early events not readily studied in human patients. The presence of certain viruses can
confound the results of AIDS-related investigations. SPF colonies have been developed using state-of-the art
assays to eliminate animals with simian immunodeficiency virus (SIV), Type D simian retrovirus (SRV) simian T-
lymphotropic virus (STLV-1); and herpes B virus (Macacine herpesvirus-1), which is a potential health risk for
personnel handling the animals. The goal of the Viral Testing Core is to provide techniques and expertise to
assure the continuing SPF status of the Ind RM breeding colony at the Southwest National Primate Research
Center (SNPRC). In order to fulfill this goal, the following Specific Aims will be completed: Specific Aim 1: to
provide a reliable and sensitive in-house viral screening method. This screening method is intended to produce
reliable results in a fast turnaround time. We will continue to use the Charles River Laboratories (CRL) Multiplex
Fluorescent ImmunoAssay (FMIA) for serological screening of all animals, which represents one of the current
state-of-the-art surveillance techniques. Specific Aim 2: to increase the research value of the SNPRC Ind RM
breeding colony by expanding serology testing. The core is ever evolving in the use of state-of-the-art techniques
and expanding to detect other pathogens of interest. In recent years, we extended our serology testing to include
detection of antibodies against measles virus and Trypanosoma cruzi. Presence of antibodies to measles is used
to confirm immune responses to the colony active measles immunization effort. Serological screening for
antibodies to the causative agent of Chagas Disease, along with PCR confirmatory testing, is used to 1) assist
animal selection; 2) to determine the prevalence of this infection in the NHP colonies; and 3) to improve and
evaluate the effectiveness of our pest control system. Finally, SNPRC has recently screened the SPF colony for
SARS-CoV-2 by both serology and PCR. Following recommendations developed by the National Primate
Research Center Pathogen Detection Working Group, the Viral Testing Core has developed an algorithm that
incorporates results from the serological viral screening with both serological and PCR confirmatory assays.
Additionally, the Core will continue to participate in activities proposed by the national Breeding Colony
Management Consortium (BCMC), which frequently distributes serum panels for proficiency testing among its
laboratory members with the intent to monitor and ensure acceptable quality testing algorithms, reagents,
methods, equipment, and personnel.
摘要-核心B:病毒检测核心
病毒检测核心是维持无特定病原体(SPF)印度人的关键组成部分
恒河猴(IndRM)(Macaca mulatta)繁殖群。感染猿猴的恒河猴
免疫缺陷病毒(SIV)是艾滋病研究的首选动物模型,并用于检查许多
病毒的发病机制,艾滋病疫苗的开发,以及探索新的全身和粘膜抗病毒方面
治疗,包括在人类患者中不容易研究的早期事件。某些病毒的存在可以
混淆了艾滋病相关调查的结果。SPF菌落已经使用最先进的
测定以消除具有猿猴免疫缺陷病毒(SIV)、D型猿猴逆转录病毒(SRV)、猿猴T-
嗜淋巴细胞病毒(STLV-1)和疱疹B病毒(猕猴疱疹病毒-1),这是一个潜在的健康风险,
管理动物的人员。病毒检测核心的目标是提供技术和专业知识,
确保西南国家灵长类动物研究所的IndRM繁殖群的持续SPF状态
中心(SNPRC)。为了实现这一目标,将完成以下具体目标:具体目标1:
提供可靠和灵敏的内部病毒筛查方法。这种筛选方法旨在产生
在快速的周转时间内获得可靠的结果。我们将继续使用Charles River Laboratories(CRL)Multiplex
荧光免疫分析(FMIA)用于所有动物的血清学筛查,这代表了当前
最先进的监视技术具体目标2:提高SNPRC Ind RM的研究价值
通过扩大血清学试验繁殖群体。核心是不断发展的使用国家的最先进的技术
并扩展到检测其他感兴趣的病原体。近年来,我们扩大了血清学检测范围,
麻疹病毒和克氏锥虫抗体检测。使用麻疹抗体的存在
以确认对殖民地群体的免疫应答积极的麻疹免疫努力。血清学筛查
恰加斯病病原体的抗体,沿着PCR确证试验,用于1)协助
动物选择; 2)确定NHP群体中这种感染的流行率;以及3)改善和
评估我们的虫害控制系统的有效性。最后,SNPRC最近对SPF群体进行了筛选,
SARS-CoV-2的血清学和PCR检测。根据国家灵长类动物委员会提出的建议,
研究中心病原体检测工作组,病毒检测核心已经开发出一种算法,
将血清学病毒筛查结果与血清学和PCR确证性试验结合起来。
此外,核心将继续参与国家育种群提出的活动
管理联盟(BCMC),该联盟经常在其成员之间分发用于能力验证的血清样本组。
实验室成员,旨在监控和确保可接受的质量测试算法,试剂,
方法、设备和人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Smriti Mehra其他文献
Smriti Mehra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Smriti Mehra', 18)}}的其他基金
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
增强抗支原体的宿主定向治疗。
- 批准号:
10610310 - 财政年份:2018
- 资助金额:
$ 3.08万 - 项目类别:
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
增强抗支原体的宿主定向治疗。
- 批准号:
10540464 - 财政年份:2018
- 资助金额:
$ 3.08万 - 项目类别:
"Role of IDO in tryptophan pathway during Mycobacterial tuberculosis infection”
“结核分枝杆菌感染期间 IDO 在色氨酸途径中的作用 –
- 批准号:
9387020 - 财政年份:2017
- 资助金额:
$ 3.08万 - 项目类别:
Characterization of Protective Immunity to MTB in a Setting of HIV Coinfection
HIV 合并感染情况下 MTB 保护性免疫的特征
- 批准号:
9204905 - 财政年份:2016
- 资助金额:
$ 3.08万 - 项目类别:
Correlates of protection from TB and TB/AIDS comorbidity
预防结核病和结核病/艾滋病合并症的相关性
- 批准号:
9203508 - 财政年份:2016
- 资助金额:
$ 3.08万 - 项目类别:
相似海外基金
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10610268 - 财政年份:2022
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10383109 - 财政年份:2021
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9915686 - 财政年份:2019
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10818316 - 财政年份:2018
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9467403 - 财政年份:2017
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9259797 - 财政年份:2016
- 资助金额:
$ 3.08万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9050566 - 财政年份:2015
- 资助金额:
$ 3.08万 - 项目类别: